Top 50 Life Science Startup Investors in Europe (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Bpifrance
VC Fund
|
28 | France, United States, Switzerland | Seed, Series A | Software, Information Technology, Health Care | $757k–$34M |
|
Parkwalk Advisors
VC Fund
|
24 | United Kingdom, United States, Philippines | Seed, Series A, Series B | Biotechnology, Health Care, Software | $991k–$45M |
|
Sofinnova Partners
VC Fund
|
22 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $7M–$105M |
|
SOSV
VC Fund
|
20 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
UK Innovation & Science Seed Fund
VC Fund
|
16 | United Kingdom, United States | Seed, Series A | Biotechnology, Health Care, Medical | $482k–$14M |
|
Oxford Science Enterprises
VC Fund
|
16 | United Kingdom, United States, Finland | Seed, Series A, Series B | Health Care, Biotechnology, Software | $1.3M–$168M |
|
Future Planet Capital
VC Fund
|
13 | United Kingdom, United States, Singapore | Seed, Convertible Note | Biotechnology, Health Care, Software | $670k–$5.1M |
|
Novo Holdings
VC Fund
|
12 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $9.5M–$135M |
|
Syncona Partners LLP
VC Fund
|
12 | United Kingdom, United States, Switzerland | Series A, Series B, Seed | Biotechnology, Medical, Health Care | $1.9M–$156M |
|
Kurma Partners
VC Fund
|
12 | France, Switzerland, Spain | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $2.7M–$98M |
|
Development Bank of Wales
VC Fund
|
11 | United Kingdom, Australia, United States | Seed, Debt Financing, Venture - Series Unknown | Software, Health Care, Manufacturing | $19k–$5.4M |
|
IQ Capital
VC Fund
|
11 | United Kingdom, United States, Germany | Seed, Series A | Software, Artificial Intelligence, Machine Learning | $1.3M–$40M |
|
Jonathan Milner
Angel
|
11 | United Kingdom, United States, Spain | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $537k–$56M |
|
24 Haymarket
VC Fund
|
11 | United Kingdom, United States | Venture - Series Unknown, Seed, Series A | Health Care, Software, Biotechnology | $107k–$16M |
|
Seventure Partners
VC Fund
|
11 | France, United States, Germany | Series A, Series B | Biotechnology, Health Care, Software | $3.3M–$63M |
|
Idinvest Partners
VC Fund
|
9 | France, United States, Germany | Series B, Series A, Venture - Series Unknown | Software, Health Care, Biotechnology | $3.9M–$66M |
|
Selvedge Venture
VC Fund
|
9 | United Kingdom, United States, Canada | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Medical | $1.1M–$30M |
|
Google Ventures
VC Fund
|
9 | United States, United Kingdom, Israel | Series A, Series B, Seed | Software, Health Care, Biotechnology | $1.2M–$121M |
|
Centre for the Development of Industrial Technology (CDTI)
VC Fund
|
9 | Spain, United States, France | Grant, Seed | Biotechnology, Health Care, Software | $167k–$15M |
|
Meusinvest (Noshaq)
VC Fund
|
9 | Belgium, France, Germany | Series A, Seed, Venture - Series Unknown | Biotechnology, Health Care, Medical | $137k–$16M |
|
Entrepreneurs First
VC Fund
|
9 | United Kingdom, United States, India | Pre-Seed, Seed, Series A | Artificial Intelligence, Software, Information Technology | $55k–$30M |
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
9 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology | $850k–$31M |
|
Angels in MedCity
VC Fund
|
8 | United Kingdom, United States | Seed, Angel | Health Care, Biotechnology, Medical | $313k–$2M |
|
European Investment Bank
VC Fund
|
8 | France, Germany, The Netherlands | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Energy | $16M–$636M |
|
Antler
VC Fund
|
8 | Singapore, Australia, United Kingdom | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $100k–$29M |
|
Maven Capital Partners
VC Fund
|
8 | United Kingdom, United States, Germany | Venture - Series Unknown, Seed, Private Equity | Software, Information Technology, SaaS | $648k–$15M |
|
Newable Private Investing
VC Fund
|
8 | United Kingdom, United States | Seed, Series A | Software, Health Care, Biotechnology | $196k–$5.6M |
|
Techstart Ventures
VC Fund
|
8 | United Kingdom, Ireland, United States | Seed, Pre-Seed | Software, Information Technology, Health Care | $197k–$4M |
|
Advent Life Sciences
VC Fund
|
8 | United States, United Kingdom, France | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $5.5M–$97M |
|
O2h Ventures
VC Fund
|
8 | United Kingdom, Hungary | Seed, Venture - Series Unknown, Series A | Biotechnology, Health Care, Pharmaceutical | $603k–$25M |
|
Scottish Enterprise
VC Fund
|
8 | United Kingdom, United States, Switzerland | Grant, Seed, Venture - Series Unknown | Biotechnology, Software, Health Care | $119k–$9.4M |
|
Capital Cell
VC Fund
|
8 | Spain, France, United States | Equity Crowdfunding, Seed, Venture - Series Unknown | Health Care, Biotechnology, Medical | $138k–$3.9M |
|
GM&C Life Sciences Fund
VC Fund
|
8 | United Kingdom, Italy, Germany | Seed, Series A | Health Care, Biotechnology, Medical | $94k–$4.2M |
|
Bullnet Capital
VC Fund
|
8 | Spain, United States, Mexico | Seed, Series A | Software, Manufacturing, Information Technology | $567k–$11M |
|
Amino Collective
VC Fund
|
7 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Artificial Intelligence | $125k–$37M |
|
Nina Capital
VC Fund
|
7 | United States, United Kingdom, Germany | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $529k–$21M |
|
Enterprise Ireland
VC Fund
|
7 | Ireland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $400k–$12M |
|
Calculus Capital
VC Fund
|
7 | United Kingdom, United States, Ireland | Venture - Series Unknown, Series A | Biotechnology, Software, Medical | $1.9M–$10M |
|
APEX Ventures
VC Fund
|
7 | Germany, United Kingdom, Austria | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, Health Care | $552k–$28M |
|
BeAble Capital
VC Fund
|
7 | Spain, Italy | Pre-Seed, Seed | Biotechnology, Manufacturing, Software | $132k–$1.2M |
|
Amadeus Capital Partners
VC Fund
|
7 | United Kingdom, United States, Spain | Series A, Seed, Series B | Software, Artificial Intelligence, Information Technology | $800k–$56M |
|
Archangels
VC Fund
|
7 | United Kingdom, United States | Venture - Series Unknown, Seed | Software, Health Care, Biotechnology | $867k–$6.3M |
|
PMV
VC Fund
|
6 | Belgium, United States, The Netherlands | Seed, Series A, Series B | Software, Biotechnology, Health Care | $1M–$43M |
|
CPT Capital
VC Fund
|
6 | United States, Israel, United Kingdom | Seed, Series A, Series B | Food and Beverage, Biotechnology, Food Processing | $1.3M–$226M |
|
Inventure
VC Fund
|
6 | Finland, Sweden, United States | Seed, Series A, Series B | Software, Information Technology, Health Care | $549k–$25M |
|
Eurazeo
VC Fund
|
6 | France, United States, Germany | Series B, Seed | Software, Information Technology, Health Care | $3.2M–$125M |
|
Practica Capital
VC Fund
|
6 | Lithuania, United Kingdom, United States | Seed, Pre-Seed, Series A | Software, B2B, Information Technology | $219k–$30M |
|
Kindred Capital
VC Fund
|
6 | United Kingdom, United States, Germany | Seed, Series A, Series B | Software, Biotechnology, Health Care | $1.4M–$73M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
6 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.8M–$50M |
|
Invivo Capital Partners
VC Fund
|
6 | Spain, France, Belgium | Seed, Series A | Biotechnology, Pharmaceutical, Health Care | $1.6M–$70M |
| Access all 50 investors in Europe Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: France, United States, Switzerland
Investor stats
- Total investments: 1646
- Round size: Seed $757k–$6.1M; Series A $2.8M–$34M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely actively investing — fresh fund, raised $27M in 2025
Portfolio highlights
- Melvan — Melvan develops, finances, builds and operates solar and wind installations, combined, where relevant, with storage facilities.
- AI-Stroke — Developer of an artificial intelligence-powered mobile application designed to assist in pre-CT/MRI stroke diagnostics. The company offers a platform that guides first responders and patients through relevant exercises for stroke detection, captures and analyzes video data, and leverages the world's largest proprietary stroke patientvideo dataset (20,000 videos and 6 million images), enabling patients with a diagnosis and outcomes by reducing delays in treatment for stroke, increasing the number of treatment procedures, and recuding the rehab costs.
- MSInsight — Explore how our cutting-edge genomic analysis uncovers actionable insights into microsatellite instability (MSI), driving targeted, personalized cancer treatments.
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Philippines
Investor stats
- Total investments: 316
- Round size: Seed $991k–$4.9M; Series A $1.6M–$14M; Series B $2.2M–$45M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
- K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
- MoA Technology — We harness the principles of natural selection to accelerate discovery for better, safer herbicides so farmers can continue to feed the world.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 348
- Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $755M in 2025
Portfolio highlights
- Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
- Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
- Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 147
- Round size: Seed $482k–$5.9M; Series A $2.9M–$14M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
- Singular Machines — Singular Machines is an engineering automation company that provides solutions to engineering issues.
- Halo X Ray Technologies — HALO X-ray Technologies - next generation X-ray diffraction technology for the aviation security, medical and process control markets.
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Finland
Investor stats
- Total investments: 202
- Round size: Seed $1.3M–$12M; Series A $6.3M–$45M; Series B $9.1M–$168M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $299M in 2022
Portfolio highlights
- Caudal Energy — Porpoise Power develops a tidal energy system using oscillating hydrofoil technology inspired by dolphin swimming mechanics.
- Singular Machines — Singular Machines is an engineering automation company that provides solutions to engineering issues.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Brilliant Ideas. Brilliant People. Brilliant Minds.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note
- Geography: United Kingdom, United States, Singapore
Investor stats
- Total investments: 264
- Round size: Seed $670k–$5.1M
- Lead/follow: 5% lead, 95% follow
- Last fund: Likely still investing — raised $23M in 2022
Portfolio highlights
- Unloq AI — Unloq is a Decision Intelligence Platform that turns your company data and live market signals into governed strategic recommendations. Approved, tracked, measured.
- Nourished — At Nourished we create innovative. personalised nutrition stacks that are truly unique to you. Vegan, waste-free and always made to order.
- K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 395
- Round size: Series A $9.5M–$133M; Series B $15M–$135M; Series C $30M–$118M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $165M in 2018
Portfolio highlights
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
- PTC Therapeutics — Translating Science. Transforming Lives.
- SCHOTT Poonawalla — SCHOTT Poonawalla is a manufacturer of pharmaceutical containers, made of neutral glass tubing. The company provides parenteral packaging systems crafted from tubular glass, serving the pharmaceutical industry with a broad range of products including vials, pre-fillable syringes, ampoules, and cartridges.
Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B, Seed
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 75
- Round size: Seed $1.9M–$17M; Series A $13M–$87M; Series B $29M–$156M
- Lead/follow: 59% lead, 41% follow
Portfolio highlights
- Apini Therapeutics — Apini is a creating novel small chemical two most prevalent types of inflammatory bowel disease.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
- Re-Aim Therapeutics — Re‑Aim Therapeutics is a UK‑based biotech start‑up developing functional cures for T cell–mediated autoimmune diseases by selectively depleting pathogenic T‑cell subsets. Its lead asset, REA‑001, is a monoclonal antibody designed to potently and precisely eliminate disease‑causing type‑17 T cells, aiming to reset the immune system and achievedurable, treatment‑free remission in multiple autoimmune conditions.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, Spain
Investor stats
- Total investments: 145
- Round size: Seed $2.7M–$14M; Series A $3.9M–$98M; Series B $12M–$72M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely actively investing — fresh fund, raised $236M in 2024
Portfolio highlights
- EvlaBio — EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs. The company's pipeline includes robust scientific antibody programs for the treatment of hepatocellular carcinoma (Phase 1 ready) and chronic kidney disease with left ventricular hypertrophy (pre-clinical).
- Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Debt Financing, Venture - Series Unknown
- Geography: United Kingdom, Australia, United States
Investor stats
- Total investments: 284
- Round size: Seed $365k–$3M; Debt Financing $19k–$3.7M; Venture - Series Unknown $383k–$5.4M
- Lead/follow: 63% lead, 37% follow
- Last fund: May invest from a new fund soon — raised $27M in 2018
Portfolio highlights
- Reacta Biotech — Reacta Biotech has been established to develop, manufacture and commercialise oral food challenge materials to pharmaceutical standards of Good Manufacturing Practice (GMP).
- Design and Supply — Design and Supply are specialist manufacturers and suppliers of Industrial Steel Doors and Architectural Products.
- MeOmics Technology — MeOmics Technology is a biotech company with a focus on improving the diagnosis and treatment of mental health illnesses. The company operates in the manufacturing industry and has a team of 9 employees. The team includes experts in Neuronal Cell Biology and Neuropsychopharmacology. The company's mission is to leverage technology to enhancethe understanding and treatment of mental health conditions.
IQ Capital is a Cambridge & London-based VC firm that invests in ‘deep tech’ companies capable of dominating their respective markets on a global scale. Initial investments at Seed and Series A range from £0.5m to £10m, with capacity for follow-on investment up to £30m through the Growth Fund. The team has achieved over 30 exits including toApple, Huawei, Google and Oracle.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 213
- Round size: Seed $1.3M–$12M; Series A $4.7M–$40M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- RevEng — RevEng.AI is a cyber security and artificial intelligence company that helps organizations understand their cyber security supply chain. RevEng.ai identifies fundamental components of closed-source program binaries and generates real-valued vector embeddings for each component.
- Mindgard — Mindgard is the leading provider of AI Red Teaming solutions.
- Imperagen — Imperagen is a biotechnology research company focused on enzyme engineering, artificial intelligence, and synthetic biology.
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 63
- Round size: Seed $537k–$25M; Series A $4.5M–$50M; Series B $1.6M–$56M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
- Nuclera — Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
24Haymarket is an investment network which included several highly-experienced private equity and venture capital investors, seasoned entrepreneurs, and senior operators. Investing up to £5 million in growth companies in the UK and Europe. They invested their own capital in direct alignment with entrepreneurs and actively support their growthagenda and join the board of the companies in which they invest. Since inception in 2011, 24Haymarket has invested in more than 50 high-growth businesses.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 108
- Round size: Seed $736k–$3.7M; Series A $1.6M–$16M; Venture - Series Unknown $107k–$4.6M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- WATR — WATR is the integrated system for real-time water or soil quality monitoring. Our products are robust, reliable, accurate, easy to use and benchmarked for accuracy.
- pixlbio (formerly DefiniGEN) — Generate metabolic disease phenotypes in primary-like human cells using the best-in-class human iPSC differentiation platform. Find out more here!
- Previsico — Discover Previsico's real-time flood forecasting solutions, designed to mitigate risks for businesses and communities worldwide.
Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series A, Series B
- Geography: France, United States, Germany
Investor stats
- Total investments: 258
- Round size: Series A $3.3M–$28M; Series B $3.4M–$63M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Flexvelop — Flexvelop is a fintech transforming the way businesses finance essential business equipment. "Flexing" is an innovative combination of leasing, renting and bank-financing terms offering a kind of Hardware-as-a-Service solution. Embedded as a payment solution, partnered manufacturers, vendors and brands are actively offering"Flexing" to their b2b customers for financing new business equipment right at the point of sale and in online shops. Flexvelop is operating in the verticals of office-it, hospitality equipment, medical devices or fitness equipment throughout Germany. Well-known manufacturers like Lenovo, WMF, or LaMarzocco are using Flexing openly or as a white-label solution. SMB customers flex equipment to grow flexibly without the usual investment risk – saving liquidity, tax and a clean balance sheet. Flexvelop is using its patented in-house financing technology, promoting a more sustainable circular economy in the same time. Flexing becomes the new standard for business equipment procurement for SMBs throughout Germany, Europe and beyond.
- Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
- Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series B, Series A, Venture - Series Unknown
- Geography: France, United States, Germany
Investor stats
- Total investments: 329
- Round size: Series A $3.9M–$22M; Series B $7.8M–$66M; Venture - Series Unknown $4.7M–$65M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $97M in 2021
Portfolio highlights
- Actility — Actility provides IoT connectivity and solutions to power smart cities and industries.
- Pretty Simple — Video games studio based in Paris, France. Makers of Criminal Case and Sorcery School.
- StarTower — StarTower is a resource company built specifically for fully decentralized physical infrastructure and shared interaction. Based on the exclusive RIP encryption technology, StarTower realizes the interactive sharing of multiple resources with zero loss on mobile devices, thereby providing efficient resource transmission for terminal facilities. Itprovides more efficient, secure and reliable solutions in the fields of Internet of Things, smart cities, industrial automation, healthcare, etc.
Selvedge Venture operates as a venture capital firm investing for impact in age-related medical conditions.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 20
- Round size: Seed $1.4M–$9.6M; Pre-Seed $1.1M–$2.5M; Series A $3.5M–$30M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Mesh Bio — We enable digital transformation of care delivery through clinical workflow automation and predictive analytics, built on gold standard clinical guidelines and best practices.
- BIOS — BIOS Health is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals.
- MultiOmic Health — AI-Enabled Precision Medicine for Metabolic Syndrome
GV supports innovative founders moving the world forward.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 1425
- Round size: Seed $1.2M–$16M; Series A $6M–$100M; Series B $16M–$121M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $100M in 2014
Portfolio highlights
- Gusto — Gusto develops web-based payroll solution for small- and medium-sized businesses. It operates an online platform that provides payroll, benefits, human resources, and integration services for employers and employees in the United States.Gusto offers health benefits and workers’ compensation benefits that include medical insurance, commuterbenefits, and 401(k) contributions as well as workers’ compensation insurance plans, time tracking, and integration services, and access to employees for processing payroll from web-enabled devices such as smartphones and tablets. It also provides access to employees and contractors to browse their previous pay stubs, review their payroll forms, verify their personal details, and statistics about their pay, tax payments and federal forms filing services, and security and support services.Gusto serves startups, coffee shops, doctors, creative agencies, lawyers, and boutiques. Edward Kim, Joshua Reeves, and Tomer London founded ZenPayRoll in 2011 that became Gusto, with its headquarters in San Francisco in California with an additional office in Denver in Colorado.
- Wonder — Introducing a new kind of home dining experience. Currently available in areas of New Jersey.
- OpenEvidence — OpenEvidence uses artificial intelligence to aggregate, synthesize, and visualize clinical evidence in understandable, clinically-useful formats that can be used to make more evidenced-based decisions and improve patient outcomes.
The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Grant, Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 221
- Round size: Seed $576k–$5.8M; Grant $167k–$15M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- FuVeX — FuVeX is dedicated to the design, manufacture, and commercialization of drones. The vision of the members of FuVeX is to improve the way in which the great institutions and companies are related to the aeronautics. Moreover, the company's mission is to provide such institutions and companies with an aircraft that allows them to solve theirmonitoring or transportation needs by flying long distances in a safe, easy and legal way.
- Orga AI — Organ AI creates generative artificial intelligence that will help people. Its headquarters is located in Palma De Mallorca, Islas Baleares, Spain.
- Phoenix Foods — Phoenix Foods uses insect farming to solve the problems of organic waste management and the requirement for high-quality proteins in animal feed.
Noshaq offers financial services to help businesses develop.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Belgium, France, Germany
Investor stats
- Total investments: 79
- Round size: Seed $137k–$6M; Series A $3.6M–$16M; Venture - Series Unknown $2M–$16M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- TrustUp — TrustUp is the home contractors platform, connects homeowners with verified quality home improvement.
- Le Fourgon — Le Fourgon provides contained drinks for home delivery. They offer milk, water, beer, wine, fruit juice, and sodas. They allow customers to have their drinks delivered free of charge during the day.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We turn exceptional individuals into funded founders. We back you first, then give you a bridge to Silicon Valley.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: United Kingdom, United States, India
Investor stats
- Total investments: 447
- Round size: Seed $567k–$6.7M; Pre-Seed $55k–$2.9M; Series A $5.1M–$30M
- Lead/follow: 25% lead, 75% follow
- Last fund: Likely actively investing — fresh fund, raised $133M in 2026
Portfolio highlights
- Sourcepulse — Your early warning system for software delivery (YC S23)
- EverSettled — Navigate the probate process with confidence. We provide a free checklist, guidance, and support to help families find clarity in the chaos of loss.
- Peripheral Labs — Peripheral Labs provides technology for live media and spatial intelligence.
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 713
- Round size: Seed $850k–$6.9M; Series A $3.1M–$31M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — raised $515M in 2022
Portfolio highlights
- Coredinate — COREDINATE is a fully integrated, professional and innovative solution for security companies, maintenance companies and care providers that helps optimize your processes, help you maintain your quality, and help you satisfy your customers. Whether it's control system, tour planning, task management or event capture: COREDINATE security ,maintenance or maintenance automates all your daily tasks and optimizes monitoring
- BlueID GmbH — Smart locks for professionals. BlueID delivers flexible, secure and convenient smart locks for all doors in and around your office.
- OMEICOS Therapeutics — OMEICOS Therapeutics is developing a novel, first-in-class, small molecule utilizing a new Mode of Action. OMEICOS' novel therapeutic strategy is based upon the discovery of natural metabolites of omega-3 fatty acids that mediate a strong anti-arrhythmic effect. In contrast to all other anti-arrhythmic drugs, OMEICOS' substances activatean endogenous cardio-protective signaling pathway that not only stabilizes the heart rhythm but shall provide curative effects to the diseased organ by preventing its electrical and structural remodeling.
Angels in MedCity is a partnership between MedCity, London Business Angels and Angels4LifeSciences. The programme aims to introduce new people to investing and investing in the healthcare/life sciences sector via investor workshops and introduce business angels to investment opportunities from highly-selected and trained companies.With aparticular focus on drug therapies, digital health and medical device technologies, Angels in MedCity brings potential investors together with life sciences experts in a programme aimed at both people who are new to investing and experienced investors who have little or no experience in the life sciences sector. The aim is to build investor understanding in the life sciences sector and support life sciences companies to gain funding to commercialise their ideas.Angels in MedCity has created a community of investors supported through a programme of investor workshops. Using case studies and tips from experienced investors in the field, the workshops explain how to identify and structure a good deal in the life sciences sector, as well as provide expert advice on tax breaks and legal issues.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Angel
- Geography: United Kingdom, United States
Investor stats
- Total investments: 20
- Round size: Seed $482k–$2M; Angel $313k–$1.2M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Calira — Calira (formerly Clustermarket). Give researchers an easy way to book equipment, improve equipment utilisation, and get structured lab usage data.
- Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
- Clustermarket — The intuitive lab management system for all academic research facilities and industrial laboratories that need to efficiently manage equipment bookings.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: France, Germany, The Netherlands
Investor stats
- Total investments: 571
- Round size: Post-IPO Debt $16M–$636M; Debt Financing $16M–$345M
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- Oceanloop — Oceanloop uses cutting-edge aquaculture technologies to transform the worldwide shrimp industry. Land-based Oceanloop shrimp farms provide high-quality, antibiotic-free, and sustainable saltwater shrimp production where consumption occurs. When compared to conventional farms, Oceanloop considerably reduces its resource utilization and environmentalfootprint.
- Wandercraft — Self- balancing and hands free movement with the innovative self-balancing feature, Atalante allows for multi-tasking and cognitive involvement as part of treatments.
- Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Singapore, Australia, United Kingdom
Investor stats
- Total investments: 2372
- Round size: Seed $158k–$4.5M; Pre-Seed $100k–$587k; Series A $4.1M–$29M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $7.5M in 2026
Portfolio highlights
- Two — Buy Now, Pay Later for your business customers. Two makes it easy and safe to offer invoice as a payment method on your e-commerce site.
- Forti Foods — The mission of Forti Foods is to enhance communities and change lives beyond the plate by fostering resilience and dignity via sustainable food innovation.
- RubiLabs — RubiLabs Inc provides a platform for unifying, monitoring, and analyzing organizational data. RubiLabs software enables analysts and operators across risk, compliance, and security teams to collaborate and interpret large volumes of information in real time. The company’s platform is designed to help institutions make sense of complex, fragmenteddata by transforming it into a coherent operational picture for risk detection, continuous monitoring, and investigative workflows.
Maven is one of the UK's leading private equity and investment firms. We provide essential capital and expertise to help businesses unlock their potential.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Venture - Series Unknown, Seed, Private Equity
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 212
- Round size: Seed $792k–$5M; Private Equity $981k–$15M; Venture - Series Unknown $648k–$8.1M
- Lead/follow: 75% lead, 25% follow
- Last fund: May invest from a new fund soon — raised $132M in 2019
Portfolio highlights
- KubeNet — We are KubeNet - a multi-award winning technology solutions provider based in Glasgow. Whether it's Managed IT, IT Support, Cloud, Connectivity, Voice or Cyber Security, we're by your side as your trusted technology partner.
- Tixserve — Secure, Trackable, Interactive Digital Tickets for Live Events
- ReadyGo Diagnostics — ReadyGo Diagnostics has invented a novel “Diagnostic Pen”. Low cost, intuitive to use from the raw sample, the ReadyGo Pen will be a game-changer in the newly emerging consumer diagnostics market, offering a yes/no answer in minutes, based on molecular analysis.
Newable: Helping over 20,000 businesses thrive annually with tailored financial products, advice, and flexible workspace solution
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 106
- Round size: Seed $196k–$3.1M; Series A $1.3M–$5.6M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
- Weldfast — Weldfast is a manufacturer and supplier of welding consumables, abrasives, chemicals, premium gas equipment, and safety products.
- EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
Techstart Ventures is a first-cheque investor for extraordinary founders pursuing uncapped global opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, Ireland, United States
Investor stats
- Total investments: 202
- Round size: Seed $249k–$4M; Pre-Seed $197k–$1.3M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Go Swag — Branded gifts for people you work with
- Saltroad — Get matched with an experienced HCPC Speech and Language Therapist based on your child's needs, your budget and your schedule. Loved by parents & children.
- Foresight — Foresight turns regulatory change into confident action. Compliance-critical teams see every change that affects their products across chemicals, sustainability, product safety, ESG, and HSE, with the evidence to act.
Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 73
- Round size: Series A $5.5M–$51M; Series B $21M–$97M; Series C $30M–$80M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Cyted — Cyted focuses on providing digital diagnostic infrastructure to drive the earlier detection of disease. Our technologies use AI and novel biomarkers to improve patient outcomes.
- Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Transforming UK biotech breakthroughs into impact. o2h Ventures offers SEIS/EIS and growth-stage funds to back visionary teams from seed to clinical success.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, Hungary
Investor stats
- Total investments: 60
- Round size: Seed $603k–$7.3M; Series A $1.9M–$25M; Venture - Series Unknown $1.1M–$2.9M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
- Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
- Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Grant, Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 389
- Round size: Seed $387k–$4.3M; Grant $119k–$4.2M; Venture - Series Unknown $928k–$9.4M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Kenoteq — Discover Kenoteq, pioneering the sustainable construction revolution with our innovative, ultra low-carbon building materials.
- QuickBlock — QUICKBLOCK delivers training environments, deployable infrastructure and force protection solutions for defence and security organisations worldwide.
- Singular Photonics — Singular Photonics is a startup that creates SPAD-based image sensors.
Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Equity Crowdfunding, Seed, Venture - Series Unknown
- Geography: Spain, France, United States
Investor stats
- Total investments: 52
- Round size: Seed $392k–$1.9M; Equity Crowdfunding $138k–$1.5M; Venture - Series Unknown $617k–$3.9M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- DYNAMICS VR — Dynamics VR provides rehab software for clinics to tackle musculoskeletal pain and movement impairments caused by brain trauma.
- Axoltis Pharma — Axoltis Pharma is a biotech company that develops drugs for degenerative and traumatic neurological disorders.
- EVis Bioscience — EVis Bioscience develops innovative gene delivery systems for targeted and personalized medicine. This includes extracellular vesicles, synthetic lipid nanoparticles, and their hybrids.
The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, Italy, Germany
Investor stats
- Total investments: 36
- Round size: Seed $94k–$1.9M; Series A $1.9M–$4.2M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
- Infex Therapeutics — Infex Therapeutics acquires, develops and licenses innovative drugs to treat pandemic infections
- Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Series A
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 68
- Round size: Seed $1M–$3.2M; Series A $567k–$11M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — raised $87M in 2023
Portfolio highlights
- FlexiiC — Reinventing the world of electronics with a revolutionary organic and flexible technology that enables a new generation of sensors and logic based on solution deposited functional inks at a low temperature, on low-cost substrates to make organic integrated circuits. Products and services FlexiiC presents design modeling services including Application Specific Integrated Circuits (ASIC) and Process ... Read more
- Bioherent — Photonic biosensors for drug allergy diagnosis
- Impetux Optics — Impetux is a worldwide key manufacturer and supplier of turnkey optical tweezers systems designed for mechanobiology studies in living cells and 3D tissues.
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 45
- Round size: Seed $2.4M–$14M; Pre-Seed $125k–$7.8M; Series A $12M–$37M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Calibre — Diagnostic testing, clinicians, and AI working together to help you deeply understand your health and how to improve it.
- Modern Relay — Modern Relay provides context graph for enterprise AI.
- Theorema — We build causal disease models to help pharmaceutical and biotech companies find promising drug targets and new indications for existing assets.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 96
- Round size: Seed $2M–$6.3M; Pre-Seed $529k–$2.4M; Series A $5M–$21M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $52M in 2025
Portfolio highlights
- Biobase — Biobase is the agentic system for clinical data, closing the gap between clinical data and better healthcare.
- Ladder Health — Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
- Woodway Assurance — Woodway Assurance provides EviData, an AI-driven software for automated privacy assurance on de-identified and synthetic datasets.
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 827
- Round size: Seed $400k–$3.2M; Series A $2.2M–$12M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $1.2M in 2021
Portfolio highlights
- nAperte —
- FlowForma — Unlock competitive advantage with FlowForma, the #1 no code digital process automation software & business process management tool. Get a free trial now!
- Future Grass Technology —
At Calculus Capital they are specialists in creating and managing tax efficient private equity funds for the individual. Funds that are ideal for today's market - offering generous tax benefits, and significant growth potential within a sensible risk profile.They look to make £2-5 million investments in established companies with provenmanagement teams and a successful product or service. Their entrepreneurial flair, combined with their experience and sound commercial judgement has resulted in a diversified investment portfolio and an impressive track record. In June 2013 Calculus Capital was top ranked in the prestigious Martin Churchill Tax Efficient Review for the 6th year in a row. The Government has recently shown its support for EIS funds, by maintaining the five generous tax benefits and widening the scope of EIS investments. These changes benefit Calculus Capital's rigorous and proven strategy. As a result they are experiencing their strongest pipeline of prospective investments yet.
Show more...Investment focus
- Industry: Biotechnology, Software, Medical
- Stage:Venture - Series Unknown, Series A
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 80
- Round size: Series A $2.5M–$10M; Venture - Series Unknown $1.9M–$7.8M
- Lead/follow: 65% lead, 35% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Edify Systems — The Human-First AI platform for multi-site food and beverage operators. Tighter margins, less waste, more time on the floor.
- Grateful — Grateful provides cashless tipping and trunk management software that integrates QR/NFC, EPOS systems, and compliance reporting.
- Resurrect Bio — Resurrect Bio is a disease resistance trait discovery company. Using AI and our high-throughput in planta screening platform we provide traits for breeders.
APEX Ventures is a deep-tech and medical focused venture capital firm, run by founders with complimentary backgrounds driven by the same mission.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, Austria
Investor stats
- Total investments: 61
- Round size: Seed $1.4M–$8M; Pre-Seed $552k–$9.1M; Series A $5.7M–$28M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
- Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
- Jago Coffee — Jago Coffee serves freshly brewed coffee beverages wherever you are through a fleet of fully electric mobile cafes.
BeAble Capital is a Science Equity Fund, therefore it is a pre-seed, seed and early stage venture capital management company specialized in the identification, valuation, launch and development of technologies in the sectors of advanced materials (nanotechnology and biotechnology), photonics, micro and nano electronics and Information andcommunications technologies (ICT) platforms.It acts as the link between scientific, entrepreneurial and investing worlds to promote the transfer of technology, the creation and the development of technology-based companies (start-ups) from private equity. The company is focused on strong intelectual property and long R&D background projects. Their work provide value at different stages of development by offering support in strategic points such as the identification of technologies, valuation, transfer, companies creation, fundraising, marketing, internationalization and administrative and managerial expertise.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Software
- Stage:Pre-Seed, Seed
- Geography: Spain, Italy
Investor stats
- Total investments: 70
- Round size: Seed $158k–$1.2M; Pre-Seed $132k–$514k
- Lead/follow: 83% lead, 17% follow
- Last fund: May invest from a new fund soon — raised $39M in 2016
Portfolio highlights
- Molecular Gate — Transformative Anti-Counterfeiting Technology. Multifunctional Level 1 Anti-Counterfeit Solutions: See-through Polargram and Reflective Polargram
- Bioinspired Materials — Bioinspired Materials is a Biotech-based entrepreneurship project with the participation of the Universitat Pompeu Fabra. The company develops wastewater valorization that produces biological products of high value in the market. BIOM was founded in 2019 and is based in Barcelona, Spain.
- Ars Magna Semiconductors — Ars Magna Semiconductors develops semiconductor chips designed for decentralized artificial intelligence applications. The company's technology operates with low energy consumption, real-time processing, and enhanced data privacy by reducing the number of operations and hardware requirements. Their chips address the global semiconductorshortage while enabling more efficient AI processing with reduced computational overhead.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 267
- Round size: Seed $800k–$9.2M; Series A $2.6M–$30M; Series B $7.2M–$56M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $85M in 2023
Portfolio highlights
- Tenzo — Tenzo is a restaurant analytics and AI forecasting platform for restaurants, pubs and cafes. Tenzo makes running restaurants easy with full data visibility.
- Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
- Respiro Diagnostics — Respiro is harnessing insights from the breath to detect lung cancer earlier, non-invasively, and without scans or radiation. Built for use in everyday care settings.
Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Venture - Series Unknown, Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 85
- Round size: Seed $1.3M–$4.1M; Venture - Series Unknown $867k–$6.3M
- Lead/follow: 54% lead, 46% follow
Portfolio highlights
- BioCaptiva — BioCaptiva develops liquid biopsy technology devices to diagnose and monitoring to detect cancers.
- Bioliberty — Engineering the future of physical and occupational therapy.
- Earth Blox — Earth Blox provides a platform for analyzing geospatial data through a visual interface for environmental and land analysis. The system enables users to build workflows using satellite imagery and other earth observation datasets without requiring extensive coding knowledge. It supports applications such as deforestation tracking, carbonmonitoring, agriculture assessment, and land use analysis.The platform integrates data sources and processing tools to help users generate insights, automate analyses, and export results for reporting or further use. It also allows collaboration across teams by sharing workflows and outputs within a unified environment. Earth Blox supports organizations working with geospatial intelligence by simplifying access to large-scale environmental data and analysis tools.
Do and dare company
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Belgium, United States, The Netherlands
Investor stats
- Total investments: 158
- Round size: Seed $1M–$4M; Series A $3M–$40M; Series B $6.6M–$43M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Biotalys — Biotalys is an Agricultural Technology (AgTech) company that employs its proprietary Agrobody technology platform to develop crop and food protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combinethe high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications.It was incorporated in 2013 and is based in the Biotech hub in Ghent, Belgium.
- Borro — Cashless deposit system
- Storm — Storm is een producent van hernieuwbare energie. Samen met ons team ontwikkelen, bouwen en exploiteren we duurzame energieprojecten over het hele land: van wind- en zonneparken tot snellaadstations en batterijopslag. Dit telkens tegen een zo laag mogelijke maatschappelijke kost.
Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials.
Show more...Investment focus
- Industry: Food and Beverage, Biotechnology, Food Processing
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 63
- Round size: Seed $1.3M–$7M; Series A $6M–$50M; Series B $16M–$226M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Shiru — Discover Shiru. We are an Ingredient Company that Identifies and Creates Functional Ingredients for the Plant-Based Industry.
- Xias Bio — Mitigate risk with flexible licensing options. Partner with us to transform your ideas into high-performance innovations optimized for efficacy and differentiation.
- Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 178
- Round size: Seed $549k–$6M; Series A $1.3M–$17M; Series B $1.3M–$25M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $140M in 2022
Portfolio highlights
- Lassie — Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets
- UpCloud — World's fastest cloud servers with a 100% uptime SLA! Sign up for a free trial today.
- Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
Eurazeo is a private equity and venture capital firm that invests in SMEs and manages a diversified portfolio of assets.With its expertise in private equity, real estate, and private debt, the group supports companies of all sizes in their development commitment through the commitment of its 235 professionals. It provides companies with thenecessary investments needed to realize their growth potential.The firm was founded in 1969 and is based in Paris, Ile-de-France, France.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Series B, Seed
- Geography: France, United States, Germany
Investor stats
- Total investments: 312
- Round size: Seed $3.2M–$16M; Series B $17M–$125M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Q Mixers — Q Mixers is a food and beverage company that makes carbonated mixers, beverages crafted from real ingredients.Its products are available in bars and restaurants, as well as in groceries and liquor stores. Flavors available: Ginger Beer, Tonic Water, Indian Tonic Water, Ginger Ale, Club Soda, Grapefruit, and Kola.It was established by JordanSilbert and Ben Karlin in Brooklyn, New York in 2007.
- Dewey’s Bakery — Dewey’s Bakery has had the privilege of offering customers deliciously sweet and savory treats that reflect the local flavors we love. Our products are baked with care, and our passion is creating moments that bring people together to slow down, celebrate life and enjoy the moment. Our bakery has become a beloved part of our hometown ofWinston-Salem, NC, and we’re now proud to offer our cookies and crackers nationwide so we can continue to delight taste buds from coast to coast!
- Celcius Logistics Solutions — India's Largest 'ONLINE " cold chain network.Book reefer vehicles, Cold Storages or get booking for your vehicle and cold storages across India instantly with the best price
Practica Capital
Show more...Investment focus
- Industry: Software, B2B, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Lithuania, United Kingdom, United States
Investor stats
- Total investments: 134
- Round size: Seed $219k–$3.3M; Pre-Seed $555k–$2.4M; Series A $2.4M–$30M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $85M in 2022
Portfolio highlights
- Creem — Creem is the all-in-one platform where software companies run payments, taxes, affiliates and revenue - together Finance for humans building online
- kopa.ai — AI agents for e-commerce growth.
- Outcraft AI — Outcraft AI is the autonomous revenue engine built to drive growth across the entire customer lifecycle.
A new model for Venture Capital where every founder we back becomes a co-owner of the fund.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 128
- Round size: Seed $1.4M–$16M; Series A $7.9M–$33M; Series B $8M–$73M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely actively investing — fresh fund, raised $8M in 2026
Portfolio highlights
- ZML — ZML is a production inference stack, purpose-built to decouple AI workloads from proprietary hardware.
- Bios Life — Bios Life is a technology-enabled healthcare company built to empower individuals to proactively manage their cancer risk, redefining personalized cancer screening and survivorship.
- Fractile — Fractile is designing AI compute systems that will enable the next generation of AI scaling: frontier model inference, 25x faster, at 1/10th the cost.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 104
- Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
- smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
- Rinri Therapeutics — Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.
Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Seed, Series A
- Geography: Spain, France, Belgium
Investor stats
- Total investments: 35
- Round size: Seed $1.6M–$13M; Series A $2.2M–$70M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $44M in 2019
Portfolio highlights
- Signadori Bio — Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
- ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
- Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Investors in Europe investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 investors investing in Europe Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!